Ligand selloff a ‘compelling accumulation opportunity,’ says H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis says the recent weakness in shares of presents a “compelling accumulation opportunity.” The investment case on Ligand is “unchanged” following its Q3 results, Pantginis tells investors in a research note. He views the selloff as “healthy,” noting the stock is “letting off of some steam after significant out-performance.” The analyst reiterates a Buy rating on Ligand with a $281 price target.

https://thefly.com/landingPageNews.php?id=2820729